Adverum Biotechnologies Market Cap

Adverum Biotechnologies has a market cap or net worth of $240.96 million as of April 16, 2024. Its market cap has increased by 251.77% in one year.

Market Cap

240.96M

Enterprise Value

210.00M

1-Year Change

251.77%

Ranking

#3507

Market Cap Chart

Since July 31, 2014, Adverum Biotechnologies's market cap has decreased from $581.50M to $240.96M, a decrease of -58.56%. That is a compound annual growth rate of -8.67%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2024	239.30M	-1.72%
Apr 12, 2024	243.50M	-1.97%
Apr 11, 2024	248.40M	-0.08%
Apr 10, 2024	248.60M	-0.28%
Apr 9, 2024	249.30M	-4.52%
Apr 8, 2024	261.10M	-0.31%
Apr 5, 2024	261.90M	-4.17%
Apr 4, 2024	273.30M	-1.37%
Apr 3, 2024	277.10M	-0.36%
Apr 2, 2024	278.10M	-3.54%
Apr 1, 2024	288.30M	-1.77%
Mar 28, 2024	293.50M	-3.55%
Mar 27, 2024	304.30M	3.61%
Mar 26, 2024	293.70M	-5.35%
Mar 25, 2024	310.30M	-6.90%
Mar 22, 2024	333.30M	8.89%
Mar 21, 2024	306.10M	-2.98%
Mar 20, 2024	315.50M	-7.88%
Mar 19, 2024	342.50M	-6.78%
Mar 18, 2024	367.40M	113.98%
Mar 15, 2024	171.70M	-1.77%
Mar 14, 2024	174.80M	-3.85%
Mar 13, 2024	181.80M	-0.60%
Mar 12, 2024	182.90M	1.16%
Mar 11, 2024	180.80M	-4.79%

View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GeneDx Holdings	250.11M
AC Immune	247.99M
Telomir Pharmaceuticals	245.76M
Puma Biotechnology	245.37M
Utah Medical Products	244.91M
Coherus BioSciences	241.66M
Quantum-Si incorporated	239.59M
Inovio Pharmaceuticals	237.21M

Market Cap Rankings